3TR
Taxonomy, Treatment, Targets and Remission - Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions
- Description
3TR is a transdisciplinary consortium that unites experts from different areas of medicine, basic sciences and bioinformatics. Among the 69 partners are academic institutions, SMEs, pharmaceutical companies and patient organisations. They all have teamed up to study a fundamental issue in medicine: the mechanisms of response and non-response to therapies, both within single disease entities and across diseases, where molecular stratification may identify shared disease taxonomies. By bringing together and harmonising data from existing academic or industry-sponsored studies, 3TR aims to identify novel biomarkers leading to improved patient management and personalised therapy.
- Coordinator
Related News
- Programme
- Horizon 2020 & sub-programmes
- Duration
- 84 months (September 2019 - August 2026)
- Project funding
- € 80,546,383.00
- Project partners
- 69
- Technology readiness level
- 0-2
- Project website
- https://www.3tr-imi.eu
